Circadian Dependence of Infarct Size and Acute Heart Failure in ST Elevation Myocardial Infarction

Aruni Seneviratna1, Gek Hsiang Lim2, Anju Devi2

  • 1Cardiac Department, National University Heart Centre, National University Hospital, Singapore, Singapore.

Plos One
|June 4, 2015
PubMed

Insights

ST-elevation myocardial infarction (STEMI) infarct size and acute heart failure risk show a circadian pattern. Symptoms starting midnight to 6 AM are linked to larger infarcts and worse outcomes, while 6 AM to noon onset shows the opposite.

Area of Science:

  • Cardiology
  • Circadian Biology
  • Biomedical Science

Background:

  • Conflicting data exists on circadian influence on ST-elevation myocardial infarction (STEMI) infarct size.
  • The impact of circadian patterns on STEMI clinical outcomes remains largely unknown.

Purpose of the Study:

  • To investigate the circadian dependence of infarct size in STEMI.
  • To determine the impact of infarct size circadian patterns on clinical outcomes.

Main Methods:

  • A study of 6,710 STEMI patients hospitalized between 2006-2009.
  • Symptom onset categorized into four 6-hour intervals.
  • Peak creatine kinase used as a surrogate marker for infarct size.

Main Results:

  • Patients with symptom onset from midnight to 6 AM had the largest infarct size (peak creatine kinase) and highest risk of acute heart failure and mortality.
  • Patients with onset from 6 AM to noon showed the smallest infarct size and lowest risk.
  • Circadian variations in acute heart failure incidence remained significant after adjusting for key clinical factors.

Conclusions:

  • A circadian pattern in infarct size and acute heart failure incidence was observed in STEMI.
  • Onset from midnight to 6 AM is associated with peak infarct size and adverse outcomes.
  • Differences in diabetes, infarct location, and reperfusion therapy may partly explain these circadian variations.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
465
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
480
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
783